nodes	percent_of_prediction	percent_of_DWPC	metapath
Naltrexone—Frequent bowel movements—Telbivudine—hepatitis B	0.0405	0.0415	CcSEcCtD
Naltrexone—Hepatitis C—Lamivudine—hepatitis B	0.031	0.0318	CcSEcCtD
Naltrexone—Abdominal pain lower—Telbivudine—hepatitis B	0.03	0.0307	CcSEcCtD
Naltrexone—Sinus headache—Telbivudine—hepatitis B	0.0293	0.03	CcSEcCtD
Naltrexone—Stiffness—Telbivudine—hepatitis B	0.0251	0.0257	CcSEcCtD
Naltrexone—Platelet count decreased—Entecavir—hepatitis B	0.0195	0.02	CcSEcCtD
Naltrexone—Loose stools—Telbivudine—hepatitis B	0.0172	0.0177	CcSEcCtD
Naltrexone—Naloxone—TLR4—hepatitis B	0.0163	0.691	CrCbGaD
Naltrexone—Pharyngolaryngeal pain—Telbivudine—hepatitis B	0.0141	0.0145	CcSEcCtD
Naltrexone—Laryngeal pain—Telbivudine—hepatitis B	0.014	0.0143	CcSEcCtD
Naltrexone—Hoarseness—Lamivudine—hepatitis B	0.0122	0.0125	CcSEcCtD
Naltrexone—Rhinorrhoea—Telbivudine—hepatitis B	0.0118	0.0121	CcSEcCtD
Naltrexone—Chest discomfort—Telbivudine—hepatitis B	0.0108	0.011	CcSEcCtD
Naltrexone—Musculoskeletal stiffness—Telbivudine—hepatitis B	0.0106	0.0109	CcSEcCtD
Naltrexone—Suicide—Lamivudine—hepatitis B	0.0104	0.0106	CcSEcCtD
Naltrexone—Suicide attempt—Lamivudine—hepatitis B	0.00948	0.00971	CcSEcCtD
Naltrexone—Pregnancy—Lamivudine—hepatitis B	0.00948	0.00971	CcSEcCtD
Naltrexone—Completed suicide—Lamivudine—hepatitis B	0.00915	0.00937	CcSEcCtD
Naltrexone—Abdominal cramps—Lamivudine—hepatitis B	0.00797	0.00816	CcSEcCtD
Naltrexone—Abdominal pain upper—Entecavir—hepatitis B	0.0077	0.00789	CcSEcCtD
Naltrexone—Throat sore—Lamivudine—hepatitis B	0.00746	0.00764	CcSEcCtD
Naltrexone—Oropharyngeal discomfort—Lamivudine—hepatitis B	0.0074	0.00757	CcSEcCtD
Naltrexone—Alanine aminotransferase increased—Adefovir Dipivoxil—hepatitis B	0.00726	0.00743	CcSEcCtD
Naltrexone—Pain in extremity—Telbivudine—hepatitis B	0.00693	0.0071	CcSEcCtD
Naltrexone—Migraine—Telbivudine—hepatitis B	0.00682	0.00698	CcSEcCtD
Naltrexone—Upper respiratory tract infection—Entecavir—hepatitis B	0.00677	0.00694	CcSEcCtD
Naltrexone—Rhinorrhoea—Lamivudine—hepatitis B	0.00664	0.0068	CcSEcCtD
Naltrexone—Dysphonia—Lamivudine—hepatitis B	0.00654	0.0067	CcSEcCtD
Naltrexone—Weight decreased—Adefovir Dipivoxil—hepatitis B	0.00643	0.00659	CcSEcCtD
Naltrexone—Abdominal pain upper—Telbivudine—hepatitis B	0.00633	0.00648	CcSEcCtD
Naltrexone—Cramp muscle—Telbivudine—hepatitis B	0.00624	0.00639	CcSEcCtD
Naltrexone—Aspartate aminotransferase increased—Telbivudine—hepatitis B	0.00624	0.00639	CcSEcCtD
Naltrexone—Nasopharyngitis—Telbivudine—hepatitis B	0.0062	0.00634	CcSEcCtD
Naltrexone—Hepatobiliary disease—Entecavir—hepatitis B	0.00615	0.0063	CcSEcCtD
Naltrexone—Alanine aminotransferase increased—Telbivudine—hepatitis B	0.00611	0.00626	CcSEcCtD
Naltrexone—Hepatobiliary disease—Adefovir Dipivoxil—hepatitis B	0.006	0.00614	CcSEcCtD
Naltrexone—Influenza—Telbivudine—hepatitis B	0.00599	0.00613	CcSEcCtD
Naltrexone—Sinusitis—Adefovir Dipivoxil—hepatitis B	0.00595	0.00609	CcSEcCtD
Naltrexone—Oropharyngeal pain—Lamivudine—hepatitis B	0.00592	0.00606	CcSEcCtD
Naltrexone—Hepatitis—Entecavir—hepatitis B	0.00583	0.00598	CcSEcCtD
Naltrexone—Abdominal discomfort—Telbivudine—hepatitis B	0.00574	0.00588	CcSEcCtD
Naltrexone—Hepatitis—Adefovir Dipivoxil—hepatitis B	0.00569	0.00583	CcSEcCtD
Naltrexone—Hypercholesterolaemia—Lamivudine—hepatitis B	0.00569	0.00582	CcSEcCtD
Naltrexone—Pharyngitis—Adefovir Dipivoxil—hepatitis B	0.00565	0.00579	CcSEcCtD
Naltrexone—Connective tissue disorder—Adefovir Dipivoxil—hepatitis B	0.00559	0.00573	CcSEcCtD
Naltrexone—Upper respiratory tract infection—Telbivudine—hepatitis B	0.00557	0.0057	CcSEcCtD
Naltrexone—Muscle twitching—Lamivudine—hepatitis B	0.00548	0.00561	CcSEcCtD
Naltrexone—Immune system disorder—Entecavir—hepatitis B	0.00527	0.0054	CcSEcCtD
Naltrexone—Buprenorphine—CYP2A6—hepatitis B	0.00524	0.223	CrCbGaD
Naltrexone—Alopecia—Entecavir—hepatitis B	0.00516	0.00528	CcSEcCtD
Naltrexone—Mental disorder—Entecavir—hepatitis B	0.00511	0.00523	CcSEcCtD
Naltrexone—Malnutrition—Entecavir—hepatitis B	0.00508	0.0052	CcSEcCtD
Naltrexone—Hepatobiliary disease—Telbivudine—hepatitis B	0.00505	0.00517	CcSEcCtD
Naltrexone—Malnutrition—Adefovir Dipivoxil—hepatitis B	0.00496	0.00508	CcSEcCtD
Naltrexone—Flatulence—Adefovir Dipivoxil—hepatitis B	0.00488	0.005	CcSEcCtD
Naltrexone—Back pain—Adefovir Dipivoxil—hepatitis B	0.00479	0.00491	CcSEcCtD
Naltrexone—Hepatitis—Telbivudine—hepatitis B	0.00479	0.00491	CcSEcCtD
Naltrexone—Pharyngitis—Telbivudine—hepatitis B	0.00476	0.00487	CcSEcCtD
Naltrexone—Connective tissue disorder—Telbivudine—hepatitis B	0.00471	0.00482	CcSEcCtD
Naltrexone—Lymphadenopathy—Lamivudine—hepatitis B	0.00458	0.00469	CcSEcCtD
Naltrexone—Phlebitis—Lamivudine—hepatitis B	0.00453	0.00464	CcSEcCtD
Naltrexone—Sleep disorder—Lamivudine—hepatitis B	0.00451	0.00462	CcSEcCtD
Naltrexone—Gastroenteritis—Lamivudine—hepatitis B	0.00441	0.00451	CcSEcCtD
Naltrexone—Cough—Adefovir Dipivoxil—hepatitis B	0.00432	0.00443	CcSEcCtD
Naltrexone—Mediastinal disorder—Telbivudine—hepatitis B	0.00432	0.00442	CcSEcCtD
Naltrexone—Unspecified disorder of skin and subcutaneous tissue—Entecavir—hepatitis B	0.00429	0.0044	CcSEcCtD
Naltrexone—Chest pain—Adefovir Dipivoxil—hepatitis B	0.00422	0.00432	CcSEcCtD
Naltrexone—Myalgia—Adefovir Dipivoxil—hepatitis B	0.00422	0.00432	CcSEcCtD
Naltrexone—Unspecified disorder of skin and subcutaneous tissue—Adefovir Dipivoxil—hepatitis B	0.00419	0.00429	CcSEcCtD
Naltrexone—Malnutrition—Telbivudine—hepatitis B	0.00417	0.00427	CcSEcCtD
Naltrexone—Anaphylactic shock—Entecavir—hepatitis B	0.00415	0.00425	CcSEcCtD
Naltrexone—Infection—Entecavir—hepatitis B	0.00412	0.00422	CcSEcCtD
Naltrexone—Thirst—Lamivudine—hepatitis B	0.0041	0.0042	CcSEcCtD
Naltrexone—Dysgeusia—Telbivudine—hepatitis B	0.00409	0.00418	CcSEcCtD
Naltrexone—Nervous system disorder—Entecavir—hepatitis B	0.00407	0.00416	CcSEcCtD
Naltrexone—Back pain—Telbivudine—hepatitis B	0.00404	0.00413	CcSEcCtD
Naltrexone—Skin disorder—Entecavir—hepatitis B	0.00403	0.00412	CcSEcCtD
Naltrexone—Muscle spasms—Telbivudine—hepatitis B	0.00401	0.00411	CcSEcCtD
Naltrexone—Nervous system disorder—Adefovir Dipivoxil—hepatitis B	0.00397	0.00406	CcSEcCtD
Naltrexone—Skin disorder—Adefovir Dipivoxil—hepatitis B	0.00393	0.00402	CcSEcCtD
Naltrexone—Ill-defined disorder—Telbivudine—hepatitis B	0.00387	0.00396	CcSEcCtD
Naltrexone—Anorexia—Adefovir Dipivoxil—hepatitis B	0.00386	0.00395	CcSEcCtD
Naltrexone—Migraine—Lamivudine—hepatitis B	0.00384	0.00394	CcSEcCtD
Naltrexone—Malaise—Telbivudine—hepatitis B	0.00376	0.00385	CcSEcCtD
Naltrexone—Insomnia—Entecavir—hepatitis B	0.00375	0.00384	CcSEcCtD
Naltrexone—Somnolence—Entecavir—hepatitis B	0.00369	0.00377	CcSEcCtD
Naltrexone—Musculoskeletal discomfort—Adefovir Dipivoxil—hepatitis B	0.00368	0.00377	CcSEcCtD
Naltrexone—Cough—Telbivudine—hepatitis B	0.00364	0.00373	CcSEcCtD
Naltrexone—Dehydration—Lamivudine—hepatitis B	0.00363	0.00372	CcSEcCtD
Naltrexone—Gastrointestinal disorder—Entecavir—hepatitis B	0.00358	0.00367	CcSEcCtD
Naltrexone—Fatigue—Entecavir—hepatitis B	0.00357	0.00366	CcSEcCtD
Naltrexone—Abdominal pain upper—Lamivudine—hepatitis B	0.00357	0.00365	CcSEcCtD
Naltrexone—Arthralgia—Telbivudine—hepatitis B	0.00355	0.00364	CcSEcCtD
Naltrexone—Chest pain—Telbivudine—hepatitis B	0.00355	0.00364	CcSEcCtD
Naltrexone—Myalgia—Telbivudine—hepatitis B	0.00355	0.00364	CcSEcCtD
Naltrexone—Unspecified disorder of skin and subcutaneous tissue—Telbivudine—hepatitis B	0.00353	0.00361	CcSEcCtD
Naltrexone—Aspartate aminotransferase increased—Lamivudine—hepatitis B	0.00352	0.0036	CcSEcCtD
Naltrexone—Cramp muscle—Lamivudine—hepatitis B	0.00352	0.0036	CcSEcCtD
Naltrexone—Decreased appetite—Adefovir Dipivoxil—hepatitis B	0.00352	0.0036	CcSEcCtD
Naltrexone—Discomfort—Telbivudine—hepatitis B	0.00351	0.00359	CcSEcCtD
Naltrexone—Gastrointestinal disorder—Adefovir Dipivoxil—hepatitis B	0.00349	0.00358	CcSEcCtD
Naltrexone—Nasopharyngitis—Lamivudine—hepatitis B	0.00349	0.00358	CcSEcCtD
Naltrexone—Alanine aminotransferase increased—Lamivudine—hepatitis B	0.00344	0.00353	CcSEcCtD
Naltrexone—Gastrointestinal pain—Entecavir—hepatitis B	0.00339	0.00347	CcSEcCtD
Naltrexone—Influenza—Lamivudine—hepatitis B	0.00337	0.00346	CcSEcCtD
Naltrexone—Nervous system disorder—Telbivudine—hepatitis B	0.00334	0.00342	CcSEcCtD
Naltrexone—Skin disorder—Telbivudine—hepatitis B	0.00331	0.00339	CcSEcCtD
Naltrexone—Gastrointestinal pain—Adefovir Dipivoxil—hepatitis B	0.00331	0.00339	CcSEcCtD
Naltrexone—Sweating increased—Lamivudine—hepatitis B	0.00329	0.00337	CcSEcCtD
Naltrexone—Abdominal pain—Entecavir—hepatitis B	0.00328	0.00336	CcSEcCtD
Naltrexone—Body temperature increased—Entecavir—hepatitis B	0.00328	0.00336	CcSEcCtD
Naltrexone—Bronchitis—Lamivudine—hepatitis B	0.00325	0.00332	CcSEcCtD
Naltrexone—Abdominal discomfort—Lamivudine—hepatitis B	0.00324	0.00331	CcSEcCtD
Naltrexone—Abdominal pain—Adefovir Dipivoxil—hepatitis B	0.0032	0.00327	CcSEcCtD
Naltrexone—Body temperature increased—Adefovir Dipivoxil—hepatitis B	0.0032	0.00327	CcSEcCtD
Naltrexone—Musculoskeletal discomfort—Telbivudine—hepatitis B	0.0031	0.00318	CcSEcCtD
Naltrexone—Insomnia—Telbivudine—hepatitis B	0.00308	0.00315	CcSEcCtD
Naltrexone—Paraesthesia—Telbivudine—hepatitis B	0.00306	0.00313	CcSEcCtD
Naltrexone—Depression—Lamivudine—hepatitis B	0.003	0.00307	CcSEcCtD
Naltrexone—Asthenia—Entecavir—hepatitis B	0.00297	0.00305	CcSEcCtD
Naltrexone—Gastrointestinal disorder—Telbivudine—hepatitis B	0.00294	0.00301	CcSEcCtD
Naltrexone—Fatigue—Telbivudine—hepatitis B	0.00294	0.00301	CcSEcCtD
Naltrexone—Pain—Telbivudine—hepatitis B	0.00291	0.00298	CcSEcCtD
Naltrexone—Asthenia—Adefovir Dipivoxil—hepatitis B	0.0029	0.00297	CcSEcCtD
Naltrexone—Pruritus—Adefovir Dipivoxil—hepatitis B	0.00286	0.00293	CcSEcCtD
Naltrexone—Hepatobiliary disease—Lamivudine—hepatitis B	0.00285	0.00291	CcSEcCtD
Naltrexone—Epistaxis—Lamivudine—hepatitis B	0.00284	0.00291	CcSEcCtD
Naltrexone—Diarrhoea—Entecavir—hepatitis B	0.00284	0.0029	CcSEcCtD
Naltrexone—Sinusitis—Lamivudine—hepatitis B	0.00282	0.00289	CcSEcCtD
Naltrexone—Feeling abnormal—Telbivudine—hepatitis B	0.00281	0.00287	CcSEcCtD
Naltrexone—Gastrointestinal pain—Telbivudine—hepatitis B	0.00278	0.00285	CcSEcCtD
Naltrexone—Diarrhoea—Adefovir Dipivoxil—hepatitis B	0.00277	0.00283	CcSEcCtD
Naltrexone—Dizziness—Entecavir—hepatitis B	0.00274	0.00281	CcSEcCtD
Naltrexone—Hepatitis—Lamivudine—hepatitis B	0.0027	0.00277	CcSEcCtD
Naltrexone—Abdominal pain—Telbivudine—hepatitis B	0.00269	0.00276	CcSEcCtD
Naltrexone—Body temperature increased—Telbivudine—hepatitis B	0.00269	0.00276	CcSEcCtD
Naltrexone—Pharyngitis—Lamivudine—hepatitis B	0.00268	0.00275	CcSEcCtD
Naltrexone—Connective tissue disorder—Lamivudine—hepatitis B	0.00265	0.00272	CcSEcCtD
Naltrexone—Vomiting—Entecavir—hepatitis B	0.00264	0.0027	CcSEcCtD
Naltrexone—Rash—Entecavir—hepatitis B	0.00261	0.00268	CcSEcCtD
Naltrexone—Dermatitis—Entecavir—hepatitis B	0.00261	0.00267	CcSEcCtD
Naltrexone—Headache—Entecavir—hepatitis B	0.0026	0.00266	CcSEcCtD
Naltrexone—Vomiting—Adefovir Dipivoxil—hepatitis B	0.00257	0.00263	CcSEcCtD
Naltrexone—Rash—Adefovir Dipivoxil—hepatitis B	0.00255	0.00261	CcSEcCtD
Naltrexone—Dermatitis—Adefovir Dipivoxil—hepatitis B	0.00255	0.00261	CcSEcCtD
Naltrexone—Headache—Adefovir Dipivoxil—hepatitis B	0.00253	0.00259	CcSEcCtD
Naltrexone—Nausea—Entecavir—hepatitis B	0.00246	0.00252	CcSEcCtD
Naltrexone—Asthenia—Telbivudine—hepatitis B	0.00244	0.0025	CcSEcCtD
Naltrexone—Immune system disorder—Lamivudine—hepatitis B	0.00244	0.0025	CcSEcCtD
Naltrexone—Mediastinal disorder—Lamivudine—hepatitis B	0.00243	0.00249	CcSEcCtD
Naltrexone—Chills—Lamivudine—hepatitis B	0.00242	0.00248	CcSEcCtD
Naltrexone—Pruritus—Telbivudine—hepatitis B	0.00241	0.00247	CcSEcCtD
Naltrexone—Nausea—Adefovir Dipivoxil—hepatitis B	0.0024	0.00246	CcSEcCtD
Naltrexone—Alopecia—Lamivudine—hepatitis B	0.00239	0.00244	CcSEcCtD
Naltrexone—Malnutrition—Lamivudine—hepatitis B	0.00235	0.00241	CcSEcCtD
Naltrexone—Diarrhoea—Telbivudine—hepatitis B	0.00233	0.00239	CcSEcCtD
Naltrexone—Flatulence—Lamivudine—hepatitis B	0.00232	0.00237	CcSEcCtD
Naltrexone—Tension—Lamivudine—hepatitis B	0.00231	0.00236	CcSEcCtD
Naltrexone—Dysgeusia—Lamivudine—hepatitis B	0.0023	0.00236	CcSEcCtD
Naltrexone—Nervousness—Lamivudine—hepatitis B	0.00228	0.00234	CcSEcCtD
Naltrexone—Back pain—Lamivudine—hepatitis B	0.00227	0.00233	CcSEcCtD
Naltrexone—Muscle spasms—Lamivudine—hepatitis B	0.00226	0.00232	CcSEcCtD
Naltrexone—Dizziness—Telbivudine—hepatitis B	0.00225	0.00231	CcSEcCtD
Naltrexone—Tremor—Lamivudine—hepatitis B	0.0022	0.00226	CcSEcCtD
Naltrexone—Ill-defined disorder—Lamivudine—hepatitis B	0.00218	0.00223	CcSEcCtD
Naltrexone—Vomiting—Telbivudine—hepatitis B	0.00217	0.00222	CcSEcCtD
Naltrexone—Angioedema—Lamivudine—hepatitis B	0.00215	0.0022	CcSEcCtD
Naltrexone—Rash—Telbivudine—hepatitis B	0.00215	0.0022	CcSEcCtD
Naltrexone—Dermatitis—Telbivudine—hepatitis B	0.00215	0.0022	CcSEcCtD
Naltrexone—Headache—Telbivudine—hepatitis B	0.00213	0.00218	CcSEcCtD
Naltrexone—Malaise—Lamivudine—hepatitis B	0.00212	0.00217	CcSEcCtD
Naltrexone—Syncope—Lamivudine—hepatitis B	0.00211	0.00216	CcSEcCtD
Naltrexone—Loss of consciousness—Lamivudine—hepatitis B	0.00207	0.00212	CcSEcCtD
Naltrexone—Cough—Lamivudine—hepatitis B	0.00205	0.0021	CcSEcCtD
Naltrexone—Convulsion—Lamivudine—hepatitis B	0.00204	0.00209	CcSEcCtD
Naltrexone—Naloxone—ALB—hepatitis B	0.00203	0.0863	CrCbGaD
Naltrexone—Nausea—Telbivudine—hepatitis B	0.00202	0.00207	CcSEcCtD
Naltrexone—Chest pain—Lamivudine—hepatitis B	0.002	0.00205	CcSEcCtD
Naltrexone—Myalgia—Lamivudine—hepatitis B	0.002	0.00205	CcSEcCtD
Naltrexone—Arthralgia—Lamivudine—hepatitis B	0.002	0.00205	CcSEcCtD
Naltrexone—Anxiety—Lamivudine—hepatitis B	0.002	0.00204	CcSEcCtD
Naltrexone—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—hepatitis B	0.00199	0.00204	CcSEcCtD
Naltrexone—Discomfort—Lamivudine—hepatitis B	0.00198	0.00203	CcSEcCtD
Naltrexone—Dry mouth—Lamivudine—hepatitis B	0.00196	0.00201	CcSEcCtD
Naltrexone—Confusional state—Lamivudine—hepatitis B	0.00194	0.00198	CcSEcCtD
Naltrexone—Anaphylactic shock—Lamivudine—hepatitis B	0.00192	0.00197	CcSEcCtD
Naltrexone—Oedema—Lamivudine—hepatitis B	0.00192	0.00197	CcSEcCtD
Naltrexone—Infection—Lamivudine—hepatitis B	0.00191	0.00195	CcSEcCtD
Naltrexone—Shock—Lamivudine—hepatitis B	0.00189	0.00193	CcSEcCtD
Naltrexone—Nervous system disorder—Lamivudine—hepatitis B	0.00188	0.00193	CcSEcCtD
Naltrexone—Skin disorder—Lamivudine—hepatitis B	0.00186	0.00191	CcSEcCtD
Naltrexone—Hyperhidrosis—Lamivudine—hepatitis B	0.00186	0.0019	CcSEcCtD
Naltrexone—Anorexia—Lamivudine—hepatitis B	0.00183	0.00187	CcSEcCtD
Naltrexone—Musculoskeletal discomfort—Lamivudine—hepatitis B	0.00175	0.00179	CcSEcCtD
Naltrexone—Insomnia—Lamivudine—hepatitis B	0.00174	0.00178	CcSEcCtD
Naltrexone—Paraesthesia—Lamivudine—hepatitis B	0.00172	0.00176	CcSEcCtD
Naltrexone—Dyspnoea—Lamivudine—hepatitis B	0.00171	0.00175	CcSEcCtD
Naltrexone—Somnolence—Lamivudine—hepatitis B	0.00171	0.00175	CcSEcCtD
Naltrexone—Decreased appetite—Lamivudine—hepatitis B	0.00167	0.00171	CcSEcCtD
Naltrexone—Gastrointestinal disorder—Lamivudine—hepatitis B	0.00166	0.0017	CcSEcCtD
Naltrexone—Fatigue—Lamivudine—hepatitis B	0.00165	0.00169	CcSEcCtD
Naltrexone—Pain—Lamivudine—hepatitis B	0.00164	0.00168	CcSEcCtD
Naltrexone—Constipation—Lamivudine—hepatitis B	0.00164	0.00168	CcSEcCtD
Naltrexone—Feeling abnormal—Lamivudine—hepatitis B	0.00158	0.00162	CcSEcCtD
Naltrexone—Gastrointestinal pain—Lamivudine—hepatitis B	0.00157	0.00161	CcSEcCtD
Naltrexone—Urticaria—Lamivudine—hepatitis B	0.00152	0.00156	CcSEcCtD
Naltrexone—Abdominal pain—Lamivudine—hepatitis B	0.00152	0.00155	CcSEcCtD
Naltrexone—Body temperature increased—Lamivudine—hepatitis B	0.00152	0.00155	CcSEcCtD
Naltrexone—Hypersensitivity—Lamivudine—hepatitis B	0.00141	0.00145	CcSEcCtD
Naltrexone—Asthenia—Lamivudine—hepatitis B	0.00138	0.00141	CcSEcCtD
Naltrexone—Pruritus—Lamivudine—hepatitis B	0.00136	0.00139	CcSEcCtD
Naltrexone—Diarrhoea—Lamivudine—hepatitis B	0.00131	0.00134	CcSEcCtD
Naltrexone—Dizziness—Lamivudine—hepatitis B	0.00127	0.0013	CcSEcCtD
Naltrexone—Vomiting—Lamivudine—hepatitis B	0.00122	0.00125	CcSEcCtD
Naltrexone—Rash—Lamivudine—hepatitis B	0.00121	0.00124	CcSEcCtD
Naltrexone—Dermatitis—Lamivudine—hepatitis B	0.00121	0.00124	CcSEcCtD
Naltrexone—Headache—Lamivudine—hepatitis B	0.0012	0.00123	CcSEcCtD
Naltrexone—Nausea—Lamivudine—hepatitis B	0.00114	0.00117	CcSEcCtD
